Sector: MedicalDr. Reddy's Laboratories Ltd (NYSE: RDY)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 157 |
Technical : | 191 |
Performance : | 134 |
Overall: | 187 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 185 |
Technical : | 50 |
Performance : | 95 |
Overall: | 70 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 186 |
Technical : | 30 |
Performance : | 75 |
Overall: | 50 |
Number of Stocks: | 305 |
Headlines
- Recovery tempered by challenges
Nov 07, 2009 01:48 PM | ABB, RDY
- Dr. Reddy’s Lab shines amid falling market
Nov 01, 2009 01:24 PM | HDB, IBN, MHP, PTI, RDY, TCL
- Biosimilars will drive growth for Dr Reddy’s, says Chairman
Oct 27, 2009 04:52 PM | MRK, RDY
- Mahindra Satyam tumbles
Oct 25, 2009 02:49 PM | HDB, IBN, INFY, RDY, SAY
- Dr Reddy’s Q2 net surges on revenue growth in generics
Oct 23, 2009 04:27 PM | RDY
- India Inc starts Q2 well
Oct 23, 2009 04:27 PM | RDY
- Dr Reddy’s in green chemistry body
Oct 20, 2009 03:25 PM | RDY
- Dr. Reddy's to release Q2 FY10 results on Oct 23, 2009; Earnings call slated for Oct 23, 6.00 PM IST / 8.30 AM EST
Oct 12, 2009 03:02 AM | RDY
- Infosys results fail to cheer IT counters
Oct 11, 2009 02:22 PM | AA, HDB, IBN, INFY, RDY, SAY
- Dr Reddy's donates Rs 1 crore
Oct 08, 2009 02:49 PM | RDY
- Dr. Reddy's Q2 FY10 Results
Oct 23, 2009 05:53 AM | RDY
- Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram®
Jul 27, 2009 07:52 AM | CGXP, RDY
- Dr. Reddy’s Q1 FY10 Results
Jul 21, 2009 07:44 AM | RDY
- Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
Jul 08, 2009 04:13 AM | RDY
- Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
Jul 08, 2009 03:17 AM | RDY
- Dr. Reddy’s Announces Strategic Alliance with GSK for Emerging Markets
Jun 15, 2009 09:28 AM | RDY
- Dr. Reddy’s Announces ANDA Approval of Omeprazole Mg OTC
Jun 09, 2009 09:51 AM | RDY
- Dr. Reddy’s Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations
May 22, 2009 03:10 AM | RDY
- Ceragenix Enters into Second Exclusive Option to License Agreement for Antimicrobial Medical Device
May 11, 2009 07:58 AM | CGXP, RDY
- Dr. Reddy’s Laboratories Realigns Global Generics Geography Portfolio
Mar 19, 2009 09:15 AM | RDY
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
RDY
|
Compare to S&P
|
| YTD |
121.74 %
|
93.29 %
|
| 4 Weeks |
14.97 %
|
13.76 %
|
| 12 Weeks |
29.42 %
|
26.21 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: 0.26 %
|
|
Sales Growth in Last Quarter: 9.77 %
|
|
